• Can predictive genomics take-off in India?  17 November 2014 | Features | By Rahul Koul Koul (Biospectrum)

Predictive Genomics industry is changing at the breath taking pace globally but India is in its early stages (Photo Courtesy: www.the-scientist.com). "The market value for predictive genomics is considered to be about Rs 100 crore," says Dr Raja Mugasimangalam, founder and CEO, Genotypic Technology. Also, an approximate estimate can be drawn based on the US market size which is predicted to grow to as much as $452 billion by 2015. This includes not only the healthcare and pharma markets but also the nutrition and wellness market opportunities that use predictive genomics.

• Antibiotics, HIV drugs can inhibit Covid-19: Study  Deccan Hearald NOV 08 2020, 01:34 IST 

Antibiotic, anti-inflammatory and HIV drugs can inhibit the Sars-CoV-2 virus which causes Covid-19, while anti-malarial medicine is less effective in fighting the disease, a new study has found.

Read more at: https://www.deccanherald.com/national/antibiotics-hiv-drugs-can-inhibit-covid-19-study-912786.html